TDOC:CA:TSX-TD Global Healthcare Leaders Index ETF (CAD)

ETF | Others |

Last Closing

CAD 18.63

Change

0.00 (0.00)%

Market Cap

CAD 0.09B

Volume

8.95K

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-01-12 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
XEF-U:CA iShares Core MSCI EAFE IMI Ind..

-0.25 (-0.96%)

CAD 6.19B
XEQT:CA iShares Core Equity Portfolio

-0.14 (-0.42%)

CAD 6.03B
CASH:CA GLOBAL X HIGH INTEREST SAVINGS..

+0.01 (+0.01%)

CAD 5.57B
PHYS-U:CA Sprott Physical Gold Trust

-0.18 (-0.87%)

CAD 4.76B
XUS-U:CA iShares Core S&P 500 Index ETF

N/A

CAD 4.54B
HXT-U:CA Global X S&P/TSX 60 Index ETF

-0.02 (-0.04%)

CAD 3.92B
CEF-U:CA Sprott Physical Gold and Silve..

-0.55 (-2.20%)

CAD 3.78B
PSLV-U:CA Sprott Physical Silver Trust

-0.24 (-2.36%)

CAD 3.29B
ZMMK:CA BMO Money Market Fund ETF Seri..

+0.01 (+0.02%)

CAD 3.24B
NSCB:CA NBI Sustainable Canadian Bond ..

+0.11 (+0.49%)

CAD 2.78B

ETFs Containing TDOC:CA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 1.47% 87% B+ 75% C
Dividend Return N/A N/A N/A N/A N/A
Total Return 1.47% 87% B+ 75% C
Trailing 12 Months  
Capital Gain 3.96% 31% F 33% F
Dividend Return 2.51% 46% F 33% F
Total Return 6.47% 30% F 31% F
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain 3.32% 52% F 45% F
Dividend Return 3.46% 50% F 39% F
Total Return 0.14% 29% F 11% F
Risk Return Profile  
Volatility (Standard Deviation) 6.09% 75% C 88% B+
Risk Adjusted Return 56.81% 72% C 68% D+
Market Capitalization 0.09B 61% D- 32% F

Annual Financials (CAD)

Quarterly Financials (CAD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:
Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.